Trial record 3 of 3 for:
HT-100
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01847573 |
|
Recruitment Status :
Terminated
(Dosing stopped)
First Posted : May 7, 2013
Last Update Posted : September 3, 2020
|
Sponsor:
Processa Pharmaceuticals
Information provided by (Responsible Party):
Processa Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | March 30, 2016 |
| Actual Study Completion Date : | March 30, 2016 |
| Certification/Extension First Submitted : | July 23, 2019 |